We've found
15,419
archived clinical trials in
Pulmonary
We've found
15,419
archived clinical trials in
Pulmonary
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Click here to add this to my saved trials
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Updated: 10/11/2013
Individualized Therapy For Asthma in Toddlers
Status: Enrolling
Updated: 10/11/2013
Click here to add this to my saved trials
Nebulized Hypertonic Saline for Mechanically Ventilated Children
Updated: 10/14/2013
Nebulized Hypertonic Saline for Mechanically Ventilated Children
Status: Enrolling
Updated: 10/14/2013
Nebulized Hypertonic Saline for Mechanically Ventilated Children
Updated: 10/14/2013
Nebulized Hypertonic Saline for Mechanically Ventilated Children
Status: Enrolling
Updated: 10/14/2013
Click here to add this to my saved trials
Predictors of Respiratory Failure Following Extubation in the SICU
Updated: 10/17/2013
Predictors of Respiratory Failure Following Extubation in Teh Surgical Intensive Care Unit (SICU)
Status: Enrolling
Updated: 10/17/2013
Predictors of Respiratory Failure Following Extubation in the SICU
Updated: 10/17/2013
Predictors of Respiratory Failure Following Extubation in Teh Surgical Intensive Care Unit (SICU)
Status: Enrolling
Updated: 10/17/2013
Click here to add this to my saved trials
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Efficacy and Tolerability of NM-BL in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Updated: 10/22/2013
A Randomized, Double-blind, Multicenter, Two-period Crossover Study to Assess the Efficacy and Tolerability of NM-BL (Burlulipase) in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
Status: Enrolling
Updated: 10/22/2013
Click here to add this to my saved trials
The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)
Updated: 10/30/2013
The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)
Status: Enrolling
Updated: 10/30/2013
The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)
Updated: 10/30/2013
The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)
Status: Enrolling
Updated: 10/30/2013
Click here to add this to my saved trials
Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases
Updated: 10/31/2013
Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases
Status: Enrolling
Updated: 10/31/2013
Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases
Updated: 10/31/2013
Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
The Effect of an Oral Antioxidant, N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis
Updated: 11/1/2013
The Effect of an Oral Antioxidant, N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis
Status: Enrolling
Updated: 11/1/2013
The Effect of an Oral Antioxidant, N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis
Updated: 11/1/2013
The Effect of an Oral Antioxidant, N-Acetyl-L-Cysteine, on Inflammatory and Oxidative Stress Markers in Pulmonary Sarcoidosis
Status: Enrolling
Updated: 11/1/2013
Click here to add this to my saved trials
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
Updated: 11/3/2013
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
Status: Enrolling
Updated: 11/3/2013
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
Updated: 11/3/2013
Viral Testing and Biomarkers to Reduce Antibiotic Use for Respiratory Infections
Status: Enrolling
Updated: 11/3/2013
Click here to add this to my saved trials
Prehospital Ventilator-Associated Pneumonia Prevention Trial
Updated: 11/7/2013
A Pilot Study of Prehospital Oral Chlorhexidine Gluconate to Prevent Early Ventilator Associated Pneumonia in Intubated Trauma Patients
Status: Enrolling
Updated: 11/7/2013
Prehospital Ventilator-Associated Pneumonia Prevention Trial
Updated: 11/7/2013
A Pilot Study of Prehospital Oral Chlorhexidine Gluconate to Prevent Early Ventilator Associated Pneumonia in Intubated Trauma Patients
Status: Enrolling
Updated: 11/7/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Progel® Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery
Updated: 11/11/2013
A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel® Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery
Status: Enrolling
Updated: 11/11/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD
Updated: 11/14/2013
A Randomized, Double Blind (Test Products and Placebo), Chronic Dosing (14 Days), Four Period, Eight Treatment, Placebo-Controlled, Incomplete Block, Cross Over, Multi Center Study to Assess Efficacy and Safety of Six Doses of PT001 in Patients With Moderate to Severe COPD, Compared With Spiriva® Handihaler® (Tiotropium Bromide, Open Label) as An Active Control
Status: Enrolling
Updated: 11/14/2013
Click here to add this to my saved trials
Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea
Updated: 11/21/2013
Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea
Status: Enrolling
Updated: 11/21/2013
Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea
Updated: 11/21/2013
Assessing the Risk of Developing Type II Diabetes Using Serum Biomarkers in Patients Diagnosed With Obstructive Sleep Apnea
Status: Enrolling
Updated: 11/21/2013
Click here to add this to my saved trials
Reiterative Development and Evaluation Study of OSA Therapy System
Updated: 11/21/2013
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
Reiterative Development and Evaluation Study of OSA Therapy System
Updated: 11/21/2013
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
Click here to add this to my saved trials
Reiterative Development and Evaluation Study of OSA Therapy System
Updated: 11/21/2013
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
Reiterative Development and Evaluation Study of OSA Therapy System
Updated: 11/21/2013
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
Click here to add this to my saved trials
Reiterative Development and Evaluation Study of OSA Therapy System
Updated: 11/21/2013
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
Reiterative Development and Evaluation Study of OSA Therapy System
Updated: 11/21/2013
A Multicenter, Prospective, Variable Duration, Reiterative Development and Evaluation Study of ApniCure's Therapy System(s) for the Treatment of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 11/21/2013
Click here to add this to my saved trials